• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估基于抗原检测的策略以缩短住院患者因严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染而采取的基于传播的预防措施的持续时间。

Evaluation of an antigen-test-based strategy to reduce duration of transmission-based precautions for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in hospitalized patients.

作者信息

Schrank Gregory M, Harris-Williams Michelle, Schiavone Kelly, Lusby Martha C, Dove Cindy, Leekha Surbhi

机构信息

Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.

University of Maryland Medical Center, Baltimore, Maryland.

出版信息

Infect Control Hosp Epidemiol. 2024 Jan;45(1):114-116. doi: 10.1017/ice.2023.164. Epub 2023 Aug 4.

DOI:10.1017/ice.2023.164
PMID:37539701
Abstract

An academic hospital implemented a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antigen-test-based strategy to facilitate discontinuation of precautions for patients admitted with a positive SARS-CoV-2 test. Of 171 patients that underwent antigen testing, 68% had an initial negative test performed a median of 5 days after admission. Antigen testing reduced isolation time by 144 hours.

摘要

一家学术医院实施了一项基于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗原检测的策略,以促进对SARS-CoV-2检测呈阳性的入院患者解除预防措施。在接受抗原检测的171名患者中,68%的患者在入院中位数5天后首次检测结果为阴性。抗原检测使隔离时间缩短了144小时。

相似文献

1
Evaluation of an antigen-test-based strategy to reduce duration of transmission-based precautions for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in hospitalized patients.评估基于抗原检测的策略以缩短住院患者因严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染而采取的基于传播的预防措施的持续时间。
Infect Control Hosp Epidemiol. 2024 Jan;45(1):114-116. doi: 10.1017/ice.2023.164. Epub 2023 Aug 4.
2
Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.急诊科入院时假设的 SARS-CoV-2 即时检测模型:快速成本效益分析。
Health Technol Assess. 2021 Mar;25(21):1-68. doi: 10.3310/hta25210.
3
Infection prevention measures in acute care settings based on severe acute respiratory syndrome coronavirus 2 transmission patterns and risk: a review.基于严重急性呼吸综合征冠状病毒 2 传播模式和风险的急性护理环境中的感染预防措施:综述。
Curr Opin Infect Dis. 2021 Aug 1;34(4):346-356. doi: 10.1097/QCO.0000000000000738.
4
Assessing past versus present severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection: A survey of criteria for discontinuing precautions in asymptomatic patients testing positive on admission.评估过去和现在的严重急性呼吸冠状病毒 2 型(SARS-CoV-2)感染:一项针对无症状入院时检测呈阳性患者停止预防措施标准的调查。
Infect Control Hosp Epidemiol. 2024 Feb;45(2):237-240. doi: 10.1017/ice.2023.147. Epub 2023 Sep 13.
5
Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020.瑞士 2020 年对住院患者进行的 SARS-CoV-2 感染普遍筛查。
Emerg Infect Dis. 2021 Feb;27(2):404-410. doi: 10.3201/eid2702.202318. Epub 2021 Jan 4.
6
Comparison of five SARS-CoV-2 rapid antigen detection tests in a hospital setting and performance of one antigen assay in routine practice: a useful tool to guide isolation precautions?医院环境中五种新型冠状病毒2型快速抗原检测试验的比较及一种抗原检测法在常规实践中的性能:指导隔离预防措施的有用工具?
J Hosp Infect. 2021 Aug;114:144-152. doi: 10.1016/j.jhin.2021.03.021. Epub 2021 Mar 27.
7
Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2.评估新型冠状病毒抗原检测试剂 Espline® SARS-CoV-2 的临床实用性。
J Infect Chemother. 2021 Feb;27(2):319-322. doi: 10.1016/j.jiac.2020.11.015. Epub 2020 Dec 23.
8
Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020.2020 年,爱荷华州一学术医疗中心对 2019 年冠状病毒病(COVID-19)患者进行入院筛查和传染性评估。
Infect Control Hosp Epidemiol. 2022 Aug;43(8):974-978. doi: 10.1017/ice.2021.294. Epub 2021 Jun 24.
9
Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)感染持续时间:何时可以安全解除隔离?
Clin Infect Dis. 2021 Apr 26;72(8):1467-1474. doi: 10.1093/cid/ciaa1249.
10
Incidence of Nosocomial COVID-19 in Patients Hospitalized at a Large US Academic Medical Center.美国一大学附属医院住院患者院内 COVID-19 感染发生率。
JAMA Netw Open. 2020 Sep 1;3(9):e2020498. doi: 10.1001/jamanetworkopen.2020.20498.